ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
95,623.80
-1.63%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) Noticias

Azitra Inc

Azitra Inc (AZTR)

AMEX
0.415
0.0198
(5.01%)
Cerrado 22 Diciembre 3:00PM
Delayed by 15 minutes
0.39
-0.025
(-6.02%)
Fuera de horario: 6:59PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

AZTR Noticias

Solo noticias oficiales

Form 8-K - Current report
Edgar (US Regulatory)
26 Noviembre 2024
AZTR (5.01%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
12 Noviembre 2024
AZTR (5.01%)

Form ARS - Annual Report to Security Holders
Edgar (US Regulatory)
09 Octubre 2024
AZTR (5.01%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
09 Octubre 2024
AZTR (5.01%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
16 Septiembre 2024
AZTR (5.01%)

AZTR Discussion

Ver más
Monksdream Monksdream 1 mes hace
AZTR, new 52/low
👍️0
Monksdream Monksdream 2 meses hace
AZTR new 52 week low
👍️0
herbied47 herbied47 3 meses hace
AZTR 800k cash on hand from Q2 balance sheet and $10M from recent offering… after recent cash burn currently $9M cash on hand and currently trading at $4M market cap. BUY!
👍️0
herbied47 herbied47 3 meses hace
Online surveys are more lucrative then this mess.
👍️0
herbied47 herbied47 3 meses hace
Swing idea. AZTR small float, recently received study may proceed letter from the FDA for INDA to treat skin rash from EGFR inhibitors, , recent offering at 1.50, recently announced three newly patents in US, China and Canada to treat inflammatory skin diseases, recent 1/30 reverse split, Maxim Group Buy rating, price target $3
👍️0
herbied47 herbied47 3 meses hace
Should be getting an update soon. Strong buy right here with this kind of low float.
👍️0
Viewmont Viewmont 4 meses hace
https://finance.yahoo.com/news/azitra-announces-first-patient-dosed-123000947.html
👍️ 1
Viewmont Viewmont 4 meses hace
Moving after hours, what's up?
👍️0
herbied47 herbied47 4 meses hace
Press releases left and right. Sabby closing their short position the other day was the first clue. This will trade not
north of $3.00 soon! Load up!
👍️0
glenn1919 glenn1919 4 meses hace
AZTR................................https://stockcharts.com/h-sc/ui?s=AZTR&p=W&b=5&g=0&id=p86431144783
👍️0
mikey4 mikey4 4 meses hace
Shoulda dumped, looked a gift horse in the mouth and said “no thanks.”
👍️0
herbied47 herbied47 4 meses hace
Gap fill. Going back up! $1.50 open
👍️0
Invest-in-America Invest-in-America 4 meses hace
AZTR; Be very careful --- merely PHASE-1, & a RARE skin disorder to boot. (Ain't goin' nowhere.)
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Nice thanks
👍️0
mikey4 mikey4 4 meses hace
Another dilution guaranteed

This is the easiest to estimate as the average duration for each phase is known. Roughly these are;

*Discovery - 3 years

*Pre-clinical - 1 year

*Phase I - 1/1.5 years

*Phase II - 1.5/2.5 years

*Phase III - 2/4 years

*Filing - 0.75 years

These are rough of course. In particular orphan drugs tend to progress faster as they can combine clinical phases.
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Waiting on volume !
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Just need some volume !
👍️0
mikey4 mikey4 4 meses hace
In 11,000 @0.63 here. Is this even close to accurate?

Here are the revenue forecasts for Azitra, Inc. (AZTR) for the next 5 years ¹:
- *2024*: No forecast available
- *2025*: $3 million
- *2026*: $0
- *2027*: $0
- *2028*: $21 million
- *2029*: $93 million
- *2030*: $165 million
- *2031*: $229 million

Please note that these forecasts are subject to change and might not reflect the company's current financial situation.
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
I will love to see after-hours run, usually they are the best, patiently waiting !
👍️0
Viewmont Viewmont 4 meses hace
Yes, let's!
👍️0
Viewmont Viewmont 4 meses hace
https://finance.yahoo.com/news/azitra-inc-announces-q2-2024-222300234.html
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Let’s have a nice squeeze $$$
👍️0
Viewmont Viewmont 4 meses hace
It's moving up! Let's go!
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Loaded and ready
👍️ 1
Viewmont Viewmont 4 meses hace
Yup! it should start going back up! https://schrts.co/ZVhEAaat
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
I like this

Completed a follow-on offering of $10 million in gross proceeds expected to provide cash runway into 2025. With the recent financing, the company anticipates announcing multiple clinical milestones
Strengthened global intellectual property portfolio with newly granted and allowed patents
Exhibited positive preclinical data from ATR-04 at the Society of Investigative Dermatology Annual Meeting
Presented positive preclinical data of ATR-12 and clinical design in Netherton Syndrome at the ASGCT Annual Meeting
Opened a Phase 1b clinical trial for ATR-12 for recruitment
👍️ 1
Viewmont Viewmont 4 meses hace
$AZTR https://www.otcmarkets.com/filing/html?id=17752131&guid=y8O-kq652gSvB3h
👍️0
Viewmont Viewmont 4 meses hace
$AZTR Trying to move up! And there's a lot of room to do so! IMO.

BRANFORD, Conn., July 25, 2024--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions.

The updated release reads:

AZITRA, INC. ANNOUNCES CLOSING OF $10.0 MILLION PUBLIC OFFERING

Azitra, Inc. (NYSE American: AZTR) ("Company"), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the closing of its previously announced public offering of an aggregate of 6,665,000 shares of its common stock, and Class A warrants to purchase up to 13,330,000 shares of common stock, at a combined public offering price of $1.50 per share and accompanying warrants. The Class A warrant will have an initial exercise price of $1.50 per share, will be exercisable immediately upon issuance, and will expire on the fifth anniversary of the original issuance date.
👍️0
Viewmont Viewmont 4 meses hace
$AZTR https://schrts.co/pStTnWQN
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Pressure building up !
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
A run of this level will be epic !
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Nice thanks
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
40s on the way !
👍️0
FROZENFLAME FROZENFLAME 5 meses hace
Not looking good, looks like 50s on the way, CEO dead silent !
👍️0
PennyPusher786 PennyPusher786 5 meses hace
Scam company. I'm 93 % down in only the past few months. Do not buy
👍️0
PennyPusher786 PennyPusher786 5 meses hace
Don't buy it
👍️0
Monksdream Monksdream 5 meses hace
AZTR new 52 week low
👍️0
herbied47 herbied47 5 meses hace
https://ir.azitrainc.com/news-releases/news-release-details/azitra-inc-strengthens-global-intellectual-property-portfolio this was just days ago of which it hit $12 then. Shoot yes here!
👍️0
PennyPusher786 PennyPusher786 5 meses hace
Up 11% from the bottom though. A averaging down would've been nice for a quick 10% profit lol...

These pricks just did a share offering though. I have my eyes on GNS CEOS BNED for a near term move
👍️0
PennyPusher786 PennyPusher786 5 meses hace
Up 11% from the bottom though. A averaging down would've been nice for a quick 10% profit lol...

These pricks just did a share offering though. I have my eyes on GNS CEOS BNED for a near term move
👍️0
PennyPusher786 PennyPusher786 5 meses hace
They're doing it to secure their pockets. God forbid they should actually earn money for once.

Fricken credit lines, and share offerings. And nieve shareholders to foot the bill... The west is finished lol...
👍️0
FROZENFLAME FROZENFLAME 5 meses hace
Same everywhere, I’m not sure how that even can be legal, check $SIDU they been doing this for the last 2 years, crazy !
👍️0
FROZENFLAME FROZENFLAME 5 meses hace
https://scr.zacks.com/news/news-details/2024/AZTR-Get-Some-Skin-in-the-Game-article/default.aspx
👍️0
PennyPusher786 PennyPusher786 5 meses hace
I would consider a provEN OTC ticker at this point such that has room to grow like $CEOS

These nasdaq bioplays suck... pure reverse Splits and share offerings and barely ever a buyout or product that comes to fruition. Just CEOs and management using retail money to keep their income rolling
👍️0
PennyPusher786 PennyPusher786 5 meses hace
These morons ran a reverse split to get the share price out of pennies, then a share offering after a run up to $12.... and immediately dumped it under $1 again.

May God curse the management with for stealing money from share holders and lining their pockets.

Disgusting
👍️0
FROZENFLAME FROZENFLAME 5 meses hace
Loading the 52WL, gambling here lol .
👍️0
Monksdream Monksdream 5 meses hace
AZTR new 52 week low
👍️0
FROZENFLAME FROZENFLAME 5 meses hace
New lows everywhere !
👍️0
FROZENFLAME FROZENFLAME 5 meses hace
New 52WL after hours .96 !
👍️0
FROZENFLAME FROZENFLAME 5 meses hace
https://www.businesswire.com/news/home/20240725675771/en/
👍️0

Su Consulta Reciente

AMEX
AZTR
Azitra
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados